Stem cell patch aims to heal failing hearts during bypass surgery
NCT ID NCT07471698
First seen Mar 24, 2026 · Last updated May 20, 2026 · Updated 9 times
Summary
This early-stage trial tests whether a patch made from human stem cells can help repair heart muscle in people with severe, end-stage heart failure who are already scheduled for bypass surgery. Sixteen participants will receive either the stem cell patch or a placebo patch during their operation. The study focuses on safety, like checking for abnormal heart rhythms or tumors, and looks for signs of improved heart function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CABG-PATIENTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Second Xiangya Hospital of Central South University
Changsha, China
Contact
Contact
Conditions
Explore the condition pages connected to this study.